Inventor · disambiguated record
Simona M. Ceccarelli
Also filed as: CECCARELLI SIMONA · CECCARELLI SIMONA M · CECCARELLI SIMONA MARIA
43 granted patents·6 pending applications·161 citations·filing 2004–2020
97Inventor score
Top patents by PatentIndex Score
49 records- 0193US7696200B2Bicyclic sulfonamide derivatives which are L-CPT1 inhibitorsHOFFMANN LA ROCHE·Filed 2007·Granted Apr 13, 2010·24 cites·26 claims
- 0292US7799933B2Sulfonamide derivativesHOFFMANN LA ROCHE·Filed 2007·Granted Sep 21, 2010·24 cites·19 claims
- 0388US7189850B2Triaza-spiropiperidine derivativesHOFFMANN LA ROCHE·Filed 2004·Granted Mar 13, 2007·30 cites·25 claims
- 0485US7879845B2Bicyclic sulfonamide derivatives which are L-CPT1 inhibitorsHOFFMANN LA ROCHE·Filed 2010·Granted Feb 1, 2011·7 cites·27 claims
- 0584US7332510B2Imidazole derivativesHOFFMANN LA ROCHE·Filed 2004·Granted Feb 19, 2008·15 cites·5 claims
- 0683US7678815B2Thiazole-4-carboxyamide derivativesHOFFMANN LA ROCHE·Filed 2006·Granted Mar 16, 2010·6 cites·25 claims
- 0781US7153874B2Imidazole derivativesHOFFMANN LA ROCHE·Filed 2004·Granted Dec 26, 2006·15 cites·27 claims
- 0880US7091222B2Imidazole derivativesHOFFMANN LA ROCHE·Filed 2004·Granted Aug 15, 2006·13 cites·11 claims
- 0976US9278918B2Urea derivatives and their use as fatty-acid binding protein (FABP) inhibitorsHOFFMANN LA ROCHE·Filed 2015·Granted Mar 8, 2016·2 cites·19 claims
- 1076US8349893B24-trimethylammonio-butyrates as CPT2 inhibitorsHOFFMANN LA ROCHE·Filed 2009·Granted Jan 8, 2013·2 cites·18 claims
- 1175US8344027B24-dimethylaminobutyric acid derivativesHOFFMANN LA ROCHE·Filed 2009·Granted Jan 1, 2013·2 cites·30 claims
- 1274US9199938B2Aryl-quinoline derivativesHOFFMANN LA ROCHE·Filed 2012·Granted Dec 1, 2015·2 cites·16 claims
- 1374US8163793B2Proline derivativesSANCHEZ RUBEN ALVAREZ·Filed 2010·Granted Apr 24, 2012·6 cites·33 claims
- 1474US7241760B2Heteroaryl-substituted imidazole derivativesHOFFMANN LA ROCHE·Filed 2004·Granted Jul 10, 2007·7 cites·15 claims
- 1573US7858645B2Indazole derivativesHOFFMANN LA ROCHE·Filed 2007·Granted Dec 28, 2010·1 cites·20 claims
- 1669US9604977B2Bicyclic thiophenylamide compoundsHOFFMANN LA ROCHE·Filed 2014·Granted Mar 28, 2017·1 cites·21 claims
- 1769US8071628B2Indazole derivativesACKERMANN JEAN·Filed 2010·Granted Dec 6, 2011·1 cites·20 claims
- 1868US9365550B2Benzimidazoles as CNS active agentsHOFFMANN LA ROCHE·Filed 2015·Granted Jun 14, 2016·1 cites·13 claims
- 1963US8293916B2Diazole derivativesBUETTELMANN BERND·Filed 2009·Granted Oct 23, 2012·0 cites·12 claims
- 2063US7973165B2Imidazole derivativesHOFFMANN LA ROCHE·Filed 2007·Granted Jul 5, 2011·0 cites·4 claims
- 2163US7531529B2Imidazole derivativesROCHE PALO ALTO LLC·Filed 2004·Granted May 12, 2009·2 cites·4 claims
- 2262US8481548B2Imidazole derivativesBUETTELMANN BERND·Filed 2007·Granted Jul 9, 2013·0 cites·18 claims
- 2360US7964620B2Imidazole derivativesHOFFMANN LA ROCHE·Filed 2008·Granted Jun 21, 2011·0 cites·6 claims
- 2460US7723538B2Sulfonamides as L-CPT1 inhibitorsHOFFMANN LA ROCHE·Filed 2006·Granted May 25, 2010·0 cites·15 claims
- 2557US7452909B2Imidazole derivativesHOFFMANN LA ROCHE·Filed 2004·Granted Nov 18, 2008·0 cites·3 claims
- 2654US8673946B24-trimethylammonio-butyrates as CPT2 inhibitorsHOFFMANN LA ROCHE·Filed 2012·Granted Mar 18, 2014·0 cites·16 claims
- 2753US2012232104A1Novel sulfonamides as l-cpt1 inhibitorsBLEICHER KONRAD·Filed 2012·Application pending·0 cites
- 2852US8030308B2Bicyclic sulfonamide derivatives which are L-CPT 1 inhibitorsHOFFMANN LA ROCHE·Filed 2010·Granted Oct 4, 2011·0 cites·24 claims
- 2951US2011319438A1Novel sulfonamides as l-cpt1 inhibitorsBLEICHER KONRAD·Filed 2011·Application pending·0 cites
- 3050US9139593B2Azetidine compounds, compositions and methods of useHOFFMANN LA ROCHE·Filed 2014·Granted Sep 22, 2015·0 cites·8 claims
- 3150US2006030559A1Diazole derivativesBUETTELMANN BERND·Filed 2005·Application pending·0 cites
- 3249US8039487B2Piperidine-amide derivativesHOFFMANN LA ROCHE·Filed 2008·Granted Oct 18, 2011·0 cites·21 claims
- 3348US2010144762A1Novel sulfonamides as l-cpt1 inhibitorsBLEICHER KONRAD·Filed 2010·Application pending·0 cites
- 3447US8809552B2Azetidine compounds, compositions and methods of useHOFFMANN LA ROCHE·Filed 2012·Granted Aug 19, 2014·0 cites·6 claims
- 3544US9809599B2Aryl-quinoline derivativesHOFFMANN LA ROCHE·Filed 2015·Granted Nov 7, 2017·0 cites·26 claims
- 3644US7173133B2Diaza-spiropiperidine derivativesHOFFMANN LA ROCHE·Filed 2005·Granted Feb 6, 2007·0 cites·52 claims
- 3743US7176316B2Amino-piperidine derivativesHOFFMANN LA ROCHE·Filed 2004·Granted Feb 13, 2007·0 cites·28 claims
- 3842US2012289554A14-dimethylaminobutyric acid derivativesANDJELKOVIC MIRJANA·Filed 2012·Application pending·0 cites
- 3940US2022152127A1Engineered lactococcusUNIV DEGLI STUDI ROMA LA SAPIENZA·Filed 2020·Application pending·0 cites
- 4039US9688675B21,7-naphthyridine derivativesHOFFMANN LA ROCHE·Filed 2016·Granted Jun 27, 2017·0 cites·11 claims
- 4137US9586903B2Isoquinoline derivativesHOFFMANN LA ROCHE·Filed 2015·Granted Mar 7, 2017·0 cites·9 claims
- 4237US9440962B2BenzisoxazolesHOFFMANN LA ROCHE·Filed 2015·Granted Sep 13, 2016·0 cites·9 claims
- 4337US9315502B2Imidazopyridine derivativesHOFFMANN LA ROCHE·Filed 2015·Granted Apr 19, 2016·0 cites·10 claims
- 4436US9708340B2Urea derivatives and their use as fatty-acid binding protein (FABP) inhibitorsHOFFMANN LA ROCHE·Filed 2015·Granted Jul 18, 2017·0 cites·3 claims
- 4536US9284321B2Piperazino[1,2-a]indol-1-ones and [1,4]diazepino[1,2-a]indol-1-oneHOFFMANN LA ROCHE·Filed 2015·Granted Mar 15, 2016·0 cites·14 claims
- 4636US7893099B2Cyclopentane derivativesHOFFMANN LA ROCHE·Filed 2010·Granted Feb 22, 2011·0 cites·19 claims
- 4735US9827292B2Use of KGF in the treatment of menopausal disordersUniversità degli Studi di Roma “La Sapienza”·Filed 2013·Granted Nov 28, 2017·0 cites·6 claims
- 4835US9657014B2Substituted 1,6-naphthyridinesHOFFMANN LA ROCHE·Filed 2015·Granted May 23, 2017·0 cites·4 claims
- 4935US9353102B2Non-annulated thiophenylamidesHOFFMANN LA ROCHE·Filed 2015·Granted May 31, 2016·0 cites·15 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →